Results of a small trial in this week's issue of THE LANCET suggest that electrical stimulation of the sacral nerve could be a future treatment option for faecal incontinence. Anal incontinence ...
Background: Sacral neuromodulation operations have usually been performed based on 2D fluoro images. However, sacral nerve stimulation lead implantation may be challenging when the normal anatomy is ...
The global sacral nerve stimulation market is witnessing significant growth due to increasing prevalence of overactive bladder and urge incontinence globally. According to the National Association for ...
LONDON--(BUSINESS WIRE)--The sacral nerve stimulation (SNS) market is poised to grow by USD 192.50 million during 2020-2024, progressing at a CAGR of over 5% during the forecast period. For a More ...
SIOUX CITY | Amanda Sweum was convinced she would have to wear diapers for the rest of her life, until the 41-year-old Sioux City woman had a small device implanted in her lower back that put an end ...
NEW HAVEN, Conn. (WTNH) — In your health update today: bowel incontinence affects more than 20 percent of adults but is often not talked about. Our guest today wants to open up communication on the ...
Several studies have demonstrated excellent results for sacral nerve stimulation (SNS) in the treatment of incapacitating fecal incontinence. The devices used for SNS are expensive, however, and no ...
Sacral nerve stimulation (SNS) is a therapeutic procedure that could be used to help women with sexual dysfunction. However, the benefits of this method in this indication should still be reviewed in ...
Chronic sacral nerve stimulation has an important role in the treatment of fecal incontinence. Newly reported findings indicate that this technique is an effective treatment for fecal incontinence ...
It's a problem nobody wants to talk about, suffering in silence and embarrassment. Of the 25 million Americans living with incontinence, 80% are women. But a pacemaker for the bladder may be the ...
The prevalence of inflammatory bowel disease (IBD) in the United States is approximately 0.9% of the general population, with ulcerative colitis (UC) affecting 0.4% and Crohn’s disease (CD) affecting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback